---
title: "Barclays Remains a Buy on Xencor (XNCR)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294334372.md"
description: "Barclays analyst Etzer Darout maintains a Buy rating on Xencor (XNCR) with a $27.00 price target. Darout, a 5-star analyst in the Healthcare sector, holds an average return of 28.0%. This contrasts with the broader market consensus, which suggests a Strong Buy for Xencor with a lower average price target of $24.10."
datetime: "2026-07-30T09:17:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294334372.md)
  - [en](https://longbridge.com/en/news/294334372.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294334372.md)
generator: "portal-rs"
---

# Barclays Remains a Buy on Xencor (XNCR)

In a report released today, Etzer Darout from Barclays maintained a Buy rating on Xencor, with a price target of $27.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Darout is a 5-star analyst with an average return of 28.0% and a 59.81% success rate. Darout covers the Healthcare sector, focusing on stocks such as Incyte, Abivax SA Sponsored ADR, and Kura Oncology.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Xencor with a $24.10 average price target.

### Related Stocks

- [XNCR.US](https://longbridge.com/en/quote/XNCR.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)
- [INCY.US](https://longbridge.com/en/quote/INCY.US.md)
- [ABVX.US](https://longbridge.com/en/quote/ABVX.US.md)
- [KURA.US](https://longbridge.com/en/quote/KURA.US.md)

## Related News & Research

- [Is Xencor (XNCR) Undervalued After Its Recent Share Price Surge?](https://longbridge.com/en/news/296565401.md)
- [Wedbush Reaffirms Their Buy Rating on Xencor (XNCR)](https://longbridge.com/en/news/293429610.md)
- [88,309 Shares in UnitedHealth Group Incorporated $UNH Purchased by Allworth Financial LP](https://longbridge.com/en/news/296749626.md)
- [Royaland adds Nazario Matachione to board of directors](https://longbridge.com/en/news/296926591.md)
- [Ausdal Financial Partners Inc. Sells 3,115 Shares of UnitedHealth Group Incorporated $UNH](https://longbridge.com/en/news/297279623.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**